奥瑞克制药 ORIC
$8.82 +$0.33 (+3.89%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $8.82 0.00%
开盘$8.61
昨收$8.49
当日区间$8.50 – $8.93
成交量556.7K
市值$914.22M
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$45.30M-16.0% YoY
净利润-$41.49M-14.1% YoY
摊薄每股收益-$0.38+19.1% YoY
自由现金流-$31.96M-3.4% YoY
经营现金流-$31.61M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
净资产收益率-39.8%
资产收益率-37.4%
投入资本回报率-39.4%
流动比率13.19
负债/资产比率5.8%
现金及投资$264.76M
净现金（净负债）$264.76M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $45.30M | $39.62M | $143.00M | $34.55M | $36.67M |
| 销售及管理费用 | $9.00M | $8.18M | $33.19M | $8.70M | $7.90M |
| -管理费用 | $9.00M | $8.18M | $33.19M | $8.70M | $7.90M |
| 研发费用 | $36.30M | $31.44M | $109.82M | $25.86M | $28.77M |
| 营业利润 | -$45.30M | -$39.62M | -$143.00M | -$34.55M | -$36.67M |
| 其他收入（支出） | $3.80M | $3.85M | $13.54M | $4.05M | $4.08M |
| 其他非经营性收入（支出） | $3.80M | $3.85M | $13.54M | $4.05M | $4.08M |
| 税前利润 | -$41.49M | -$35.77M | -$129.47M | -$30.51M | -$32.59M |
| 净利润 | -$41.49M | -$35.77M | -$129.47M | -$30.51M | -$32.59M |
| 持续经营利润 | -$41.49M | -$35.77M | -$129.47M | -$30.51M | -$32.59M |
| 归属母公司净利润 | -$41.49M | -$35.77M | -$129.47M | -$30.51M | -$32.59M |
| 归属普通股股东净利润 | -$41.49M | -$35.77M | -$129.47M | -$30.51M | -$32.59M |
| 基本每股收益 | -$0.38 | -$0.34 | -$1.47 | -$0.30 | -$0.33 |
| 摊薄每股收益 | -$0.38 | -$0.34 | -$1.47 | -$0.30 | -$0.33 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $404.69M | $436.76M | $408.89M | $408.89M | $431.19M |
| 流动资产合计 | $273.70M | $290.23M | $288.47M | $288.47M | $295.59M |
| 现金及现金等价物与短期投资 | $264.76M | $281.93M | $281.49M | $281.49M | $287.14M |
| -现金及现金等价物 | $37.48M | $56.40M | $45.67M | $45.67M | $49.67M |
| -短期投资 | $227.28M | $225.54M | $235.82M | $235.82M | $237.47M |
| 其他流动资产 | $8.93M | $8.30M | $6.98M | $6.98M | $8.45M |
| 非流动资产合计 | $130.99M | $146.53M | $120.42M | $120.42M | $135.60M |
| 固定资产净值 | $2.24M | $2.15M | $2.42M | $2.42M | $2.56M |
| -固定资产原值 | $10.43M | $10.07M | $10.07M | $10.07M | $10.72M |
| -累计折旧 | -$8.19M | -$7.92M | -$7.65M | -$7.65M | -$8.16M |
| 投资及预付款 | $122.80M | $137.78M | $110.76M | $110.76M | $125.91M |
| -可供出售证券 | $122.80M | $137.78M | $110.76M | $110.76M | $125.91M |
| 其他非流动资产 | $5.95M | $6.60M | $7.25M | $7.25M | $7.13M |
| 负债合计 | $23.43M | $21.21M | $24.53M | $24.53M | $24.27M |
| 流动负债合计 | $20.76M | $17.77M | $20.42M | $20.42M | $20.18M |
| 应付款 | $3.87M | $2.90M | $3.82M | $3.82M | $2.90M |
| -应付账款 | $3.87M | $2.90M | $3.82M | $3.82M | $2.90M |
| 一年内应计费用 | $8.44M | $7.78M | $5.17M | $5.17M | $7.11M |
| 短期债务及融资租赁负债 | $3.33M | $3.30M | $3.33M | $3.33M | $3.30M |
| -一年内到期融资租赁负债 | $3.33M | $3.30M | $3.33M | $3.33M | $3.30M |
| 非流动负债合计 | $2.67M | $3.43M | $4.11M | $4.11M | $4.09M |
| 其他非流动负债 | $2.67M | $3.43M | $4.11M | $4.11M | $4.09M |
| 股东权益合计 | $381.26M | $415.56M | $384.36M | $384.36M | $406.92M |
| 股东权益 | $381.26M | $415.56M | $384.36M | $384.36M | $406.92M |
| 股本 | $11,000.00 | $11,000.00 | $11,000.00 | $11,000.00 | $11,000.00 |
| -普通股 | $11,000.00 | $11,000.00 | $11,000.00 | $11,000.00 | $11,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $1.15B | $1.14B | $1.08B | $1.08B | $1.07B |
| 留存收益 | -$769.50M | -$728.01M | -$692.24M | -$692.24M | -$661.74M |
| 不影响留存收益的损益 | -$1.02M | -$290,000.00 | $786,000.00 | $786,000.00 | $615,000.00 |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$31.61M | -$32.44M | -$110.97M | -$22.48M | -$25.11M |
| 持续经营经营活动现金流净额 | -$31.61M | -$32.44M | -$110.97M | -$22.48M | -$25.11M |
| 持续经营净利润 | -$41.49M | -$35.77M | -$129.47M | -$30.51M | -$32.59M |
| 折旧、折耗与摊销 | $264,000.00 | $270,000.00 | $1.22M | $320,000.00 | $288,000.00 |
| 营运资金变动 | $2.24M | -$4.00M | -$5.46M | $1.66M | $2.14M |
| -预付资产变动 | $21,000.00 | -$679,000.00 | $1.79M | $2.11M | $782,000.00 |
| -应付账款及应计费用变动 | $2.22M | -$3.32M | -$7.25M | -$448,000.00 | $1.36M |
| 投资活动现金流净额 | $11.86M | -$17.98M | -$148.03M | $16.98M | -$110.54M |
| 持续经营投资活动现金流净额 | $11.86M | -$17.98M | -$148.03M | $16.98M | -$110.54M |
| 固定资产购置及出售净额 | -$356,000.00 | -$2,000.00 | -$712,000.00 | -$227,000.00 | -$35,000.00 |
| 投资购置及出售净额 | $12.22M | -$17.97M | -$147.32M | $17.21M | -$110.50M |
| 筹资活动现金流 | $828,000.00 | $61.14M | $245.26M | $1.50M | $109.45M |
| 持续经营筹资活动现金流净额 | $828,000.00 | $61.14M | $245.26M | $1.50M | $109.45M |
| 普通股发行净额 | $0.00 | $60.88M | $244.37M | $0.00 | $110.44M |
| 股票期权行使所得 | $828,000.00 | $1.25M | $3.29M | $1.50M | $748,000.00 |
| 其他筹资费用净额 | $0.00 | -$993,000.00 | -$2.40M | $0.00 | -$1.74M |
| 期末现金余额 | $37.97M | $56.89M | $46.16M | $46.16M | $50.16M |
| 现金净变动 | -$18.91M | $10.73M | -$13.74M | -$4.00M | -$26.20M |
| 期初现金余额 | $56.89M | $46.16M | $59.90M | $50.16M | $76.36M |
| 自由现金流 | -$31.96M | -$32.44M | -$111.68M | -$22.71M | -$25.15M |
暂无评论——快来第一个聊聊 ORIC。
登录后参与讨论。